Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Ro vs Henry Meds

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #16EditorialDesk pick
Ro

A heavyweight platform with brand-name access — but opaque compounded pricing clouds its dispatch.

vs
Dispatch #23Editorial
Henry Meds

A flat-fee compounded pioneer — simple model, but now priced at the higher end of the market.

Ro takes this head-to-head with the higher Desk Score, 81/100 (B−) against 77/100 (C+) for Henry Meds. Henry Meds still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Ro

81/100

B−

Overall

Henry Meds

77/100

C+

Price transparency

62
70

State access

84
80

Molecule range

88
82

Onboarding speed

78
76

Support responsiveness

82
78

Licensing & trust

84
80

The spec sheet

FieldRoHenry Meds
SemaglutideNot disclosed$249/mo
TirzepatideNot disclosed$349/mo
CoverageMulti-stateMulti-state
Brand-nameYesCompounded only
Oral optionYesInjectable only
Best forPatients who want brand-name capability and insurance navigation support.People who want a simple, well-known flat-fee brand without complexity.
Desk Score81/100B−77/100C+

The verdict

Desk pick — Ro

Ro takes this head-to-head with the higher Desk Score, 81/100 (B−) against 77/100 (C+) for Henry Meds. Henry Meds still holds its ground where its strengths line up with yours.

Choose Ro if…

Patients who want brand-name capability and insurance navigation support.

Not disclosed sema · Not disclosed tirz · Multi-state

Choose Henry Meds if…

People who want a simple, well-known flat-fee brand without complexity.

$249/mo sema · $349/mo tirz · Multi-state

Neither provider here is a commercial partner. Read full breakdowns: Ro · Henry Meds.

Also on the board

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete board.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.